Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Test Us Bank

PROVIDER: PRJNA988108 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR25037600_1.fastq.gz	Fastqsanger.gz
	SRR25037600_2.fastq.gz	Fastqsanger.gz
	SRR25037700_1.fastq.gz	Fastqsanger.gz
	SRR25037700_2.fastq.gz	Fastqsanger.gz
	SRR25037800_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 1164

Similar Datasets

Rapid Acceleration of Diagnostics - TECH (RADx-TECH): Test US Bank Study

Project description:Rapid Acceleration of Diagnostics - TECH (RADx-TECH): Test US Bank Study

| PRJNA869822 | ENA

Rapid Acceleration of Diagnostics - TECH (RADx-TECH): Test US Bank Study

Project description:Rapid Acceleration of Diagnostics - TECH (RADx-TECH): Test US Bank Study

| PRJNA869823 | ENA

Predicting Relapse in Patients With Medulloblastoma by Integrating Evidence From Clinical and Genomic Feature

Project description:Despite significant progress in the molecular understanding of medulloblastoma, stratification of risk in patients remains a challenge. Focus has shifted from clinical parameters to molecular markers, such as expression of specific genes and selected genomic abnormalities, to improve accuracy of treatment outcome prediction. Here, we show how integration of high-level clinical and genomic features or risk factors, including disease subtype, can yield more comprehensive, accurate, and biologically interpretable prediction models for relapse versus no-relapse classification. We also introduce a novel Bayesian nomogram indicating the amount of evidence that each feature contributes on a patient-by-patient basis. The training set consisted of 96 samples for which relapse status at 30 months post-treatment was known. Matched normal blood samples were collected through the COG Tumor Bank (protocol ACNS02B3) and from Children's Hospital Boston under institutional review board approval. The test set included 78 samples: 47 samples from our original study6 not used for training, 16 samples from Kool et al,33 and 15 samples from the COG Tumor Bank. All training and test samples correspond to patients at least 3 years old treated with conventional chemotherapy, surgical resection, and craniospinal irradiation. In the test set, 15 samples (Children's Oncology Group Tumor Bank) were processed as described above. Of those 15, a total of six have DNA copy number data. Another set of 47 samples was taken from the data set from Pomeroy et al. (Affymetrix Hu6800; Affymetrix). None of those samples had DNA copy number data. The remaining 16 samples, all with DNA copy number data, came from Kool et al. (Affymetrix U133; Affymetrix).

2022-04-28 | GSE201583 | GEO

SNParray data for banking lines in Korea National Stem Cell Bank

Project description:Copy number variantions (CNVs) were calculated using SNP array data for banking lines in Korea National Stem Cell Bank.

2021-01-05 | GSE163134 | GEO

MiRNA and lung cancer (INCA project) - 40 miRNAs microarrays

Project description:MicroRNA expression pattern in 20 pairs of primary lung cancers and their corresponding non cancerous lung tissues. These specimens were obtained from the Nice Hospital Tumor Bio Bank, France.

2010-10-01 | GSE18692 | GEO

test

Project description:test test

| PRJEB44966 | ENA

Project description:test test

| PRJEB53402 | ENA

Project description:Marine microbiome bank

| PRJNA820521 | ENA

Project description:Maharashtra gene bank

| PRJNA450201 | ENA

Effects of coronary artery disease-associated variants on vascular smooth muscle cells

Project description:We undertook RNA-sequencing analysis on a large bank (n = 1,499) of vascular smooth muscle cells (VSMCs).